Proprietary Discovery Platform: Peptidream's highly differentiated Peptide Discovery Platform System (PDPS) is a leading technology for identifying high-affinity, cell-permeable, and stable macrocyclic peptides against a wide range of targets.

Vast Peptide Library: They possess an unparalleled, proprietary library of synthetic macrocyclic peptides, offering a chemical space and diversity significantly larger and more accessible than traditional discovery methods.

Strategic Pharma Partnerships: Peptidream has established numerous high-value, long-term collaboration agreements with global pharmaceutical companies, validating their technology and providing a stable revenue stream through upfront payments, milestones, and royalties.